Cytoplasmic Overexpression of HER2: a Key Factor in Colorectal Cancer
作者： Erik J Blok , Peter JK Kuppen , Jeroen EM van Leeuwen , Cornelis FM Sier , None
DOI: 10.4137/CMO.S10811
关键词:
摘要: … a better agreement with HER2 gene amplification, as determined by FISH (fluorescence in situ … with FISH, while the 2+ results are more equivocal.Current guidelines demand a FISH-…
sagepub.com
ru.nl
la-press.com参考文章(58)
B. Porcelli, B. Frosi, L. Terzuoli, L. Arezzini, E. Marinello, R. Vernillo, A. De Martino, R. Vatti, C. Minacci, Expression of p185 and p53 in benign and malignant colorectal lesions. Histochemical Journal. ,vol. 33, pp. 51- 57 ,(2001) , 10.1023/A:1017543930661
Thomas Knösel, Youngwei Yu, Ulrike Stein, Holger Schwabe, Karsten Schlüns, Peter Michael Schlag, Manfred Dietel, Iver Petersen, Overexpression of c-erbB-2 protein correlates with chromosomal gain at the c-erbB-2 locus and patient survival in advanced colorectal carcinomas Clinical & Experimental Metastasis. ,vol. 19, pp. 401- 407 ,(2002) , 10.1023/A:1016368708107
B Schuell, T Gruenberger, W Scheithauer, Ch Zielinski, F Wrba, HER 2/neu protein expression in colorectal cancer. BMC Cancer. ,vol. 6, pp. 123- 123 ,(2006) , 10.1186/1471-2407-6-123
Rachel Schiff, Carolina Gutierrez, HER2: biology, detection, and clinical implications. Archives of Pathology & Laboratory Medicine. ,vol. 135, pp. 55- 62 ,(2011) , 10.1043/2010-0454-RAR.1
Anne‐Sofie Schrohl, Hans Christian Pedersen, Sussie Steen Jensen, Signe Lykke Nielsen, Nils Brünner, Human epidermal growth factor receptor 2 (HER2) immunoreactivity: specificity of three pharmacodiagnostic antibodies Histopathology. ,vol. 59, pp. 975- 983 ,(2011) , 10.1111/J.1365-2559.2011.04034.X
Amanda McCann, Peter A. Dervan, P. A. Johnston, Desmond N. Carney, William J. Gullick, c-erbB-2 oncoprotein expression in primary human tumors Cancer. ,vol. 65, pp. 88- 92 ,(1990) , 10.1002/1097-0142(19900101)65:1<88::AID-CNCR2820650119>3.0.CO;2-Z
A.M. Kluftinger, B.W. Robinson, N.F. Quenville, R.J. Finley, N.L. Davis, Correlation of epidermal growth factor receptor and c-erbB2 oncogene product to known prognostic indicators of colorectal cancer. Surgical Oncology-oxford. ,vol. 1, pp. 97- 105 ,(1992) , 10.1016/0960-7404(92)90062-P
Kitty Pavlakis, Panteleimon Kountourakis, Efstathios Stathopoulos, Amanda Psyrri, Dimitra Rontogianni, Maria Kafousi, Maria Derivianaki, Nikolaos Xiros, Dimitrios Pectasides, Theofanis Economopoulos, Her-2 protein expression, cellular localization, and gene amplification in colorectal carcinoma. Applied Immunohistochemistry & Molecular Morphology. ,vol. 15, pp. 441- 445 ,(2007) , 10.1097/01.PAI.0000213156.94804.B5
A H Arnaout, P M Dawson, S Soomro, P Taylor, N A Theodorou, M Feldmann, B M Fendly, H M Shepard, S Shousha, HER2 (c-erbB-2) oncoprotein expression in colorectal adenocarcinoma: an immunohistological study using three different antibodies. Journal of Clinical Pathology. ,vol. 45, pp. 726- 727 ,(1992) , 10.1136/JCP.45.8.726
Elizabeth Half, Russell Broaddus, Kathleen D. Danenberg, Peter V. Danenberg, Gregory D. Ayers, Frank A. Sinicrope, HER-2 receptor expression, localization, and activation in colorectal cancer cell lines and human tumors International Journal of Cancer. ,vol. 108, pp. 540- 548 ,(2004) , 10.1002/IJC.11599